Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm J O'Rourke

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Digestive Diseases (Basel, Switzerland)|May 13, 2016
Molecular Pathogenesis and Current Therapy in Intrahepatic CholangiocarcinomaDan Høgdall, Colm J O'Rourke, Andrzej Taranta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025
Personalized Neoadjuvant Chemotherapy for Gastrointestinal Cancers: Shaping Imprecision to be PreciseDan Høgdall, Jakob V Schou, Julia Johanna Almer Bromann, et al.
Pharmacology & Therapeutics|January 29, 2013
Manipulating the epigenome for the treatment of urological malignanciesColm J O'Rourke, Vinicius Knabben, Eva Bolton, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|April 23, 2021
DNA Methylation in Ovarian Tumors-a Comparison Between Fresh Tissue and FFPE SamplesDouglas V N P Oliveira, Julie Hentze, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|June 19, 2019
Identification of a Pan-Gamma-Secretase Inhibitor Response Signature for Notch-Driven CholangiocarcinomaColm J O'Rourke, Matthias S Matter, Chirag Nepal, et al.
Molecular Diagnosis & Therapy|October 16, 2024
Developing a DNA Methylation Signature to Differentiate High-Grade Serous Ovarian Carcinomas from Benign Ovarian TumorsDouglas V N P Oliveira, Edyta Biskup, Colm J O'Rourke, et al.
Frontiers in Oncology|July 5, 2023
Preoperative immunological plasma markers TRAIL, CSF1 and TIE2 predict survival after resection for biliary tract cancerHannes Jansson, Martin Cornillet, Dan Sun, et al.
Journal of Clinical and Experimental Hepatology|April 18, 2025
Validation of Two Prognostic Gene Scores in Patients Undergoing Liver Resection for Hepatocellular CarcinomaStinna D Schnabl, Jeanett Klubien, Colm J O'Rourke, et al.
Clinical Epigenetics|August 29, 2021
Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancerRomina Silva, Bruce Moran, Anne-Marie Baird, et al.
Haematologica|November 12, 2020
Structural aberrations are associated with poor survival in patients with clonal cytopenia of undetermined significanceStine U Mikkelsen, Setareh Safavi, Konstantinos Dimopoulos, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Digestive Diseases (Basel, Switzerland)|May 13, 2016
Molecular Pathogenesis and Current Therapy in Intrahepatic CholangiocarcinomaDan Høgdall, Colm J O'Rourke, Andrzej Taranta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025
Personalized Neoadjuvant Chemotherapy for Gastrointestinal Cancers: Shaping Imprecision to be PreciseDan Høgdall, Jakob V Schou, Julia Johanna Almer Bromann, et al.
Pharmacology & Therapeutics|January 29, 2013
Manipulating the epigenome for the treatment of urological malignanciesColm J O'Rourke, Vinicius Knabben, Eva Bolton, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|April 23, 2021
DNA Methylation in Ovarian Tumors-a Comparison Between Fresh Tissue and FFPE SamplesDouglas V N P Oliveira, Julie Hentze, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|June 19, 2019
Identification of a Pan-Gamma-Secretase Inhibitor Response Signature for Notch-Driven CholangiocarcinomaColm J O'Rourke, Matthias S Matter, Chirag Nepal, et al.
Molecular Diagnosis & Therapy|October 16, 2024
Developing a DNA Methylation Signature to Differentiate High-Grade Serous Ovarian Carcinomas from Benign Ovarian TumorsDouglas V N P Oliveira, Edyta Biskup, Colm J O'Rourke, et al.
Frontiers in Oncology|July 5, 2023
Preoperative immunological plasma markers TRAIL, CSF1 and TIE2 predict survival after resection for biliary tract cancerHannes Jansson, Martin Cornillet, Dan Sun, et al.
Journal of Clinical and Experimental Hepatology|April 18, 2025
Validation of Two Prognostic Gene Scores in Patients Undergoing Liver Resection for Hepatocellular CarcinomaStinna D Schnabl, Jeanett Klubien, Colm J O'Rourke, et al.
Clinical Epigenetics|August 29, 2021
Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancerRomina Silva, Bruce Moran, Anne-Marie Baird, et al.
Haematologica|November 12, 2020
Structural aberrations are associated with poor survival in patients with clonal cytopenia of undetermined significanceStine U Mikkelsen, Setareh Safavi, Konstantinos Dimopoulos, et al.
Pageof 5